202000-98-4 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 2-cyano-2-(2,6-difluorophenyl)acetate is utilized as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique structure allows for the creation of a diverse range of medicinal compounds, enhancing the industry's capacity to address various health conditions.
Used in Organic Synthesis:
As a versatile intermediate in organic synthesis, Ethyl 2-cyano-2-(2,6-difluorophenyl)acetate is employed for the preparation of complex organic molecules. Its ability to introduce the ethyl ester functional group makes it a valuable component in the synthesis of a wide array of organic compounds.
Used in Medicinal Chemistry:
Ethyl 2-cyano-2-(2,6-difluorophenyl)acetate is used as a key intermediate in medicinal chemistry for the design and synthesis of novel drug candidates. Its structural features facilitate the exploration of new chemical space, potentially leading to the discovery of innovative treatments for various diseases.
Used in Agrochemicals:
In the agrochemical industry, Ethyl 2-cyano-2-(2,6-difluorophenyl)acetate finds application in the development of new pesticides and other agricultural chemicals. Its reactivity and functional group introduction capabilities are leveraged to create compounds that can effectively address pest control and crop protection needs.
Check Digit Verification of cas no
The CAS Registry Mumber 202000-98-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,0,0 and 0 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 202000-98:
(8*2)+(7*0)+(6*2)+(5*0)+(4*0)+(3*0)+(2*9)+(1*8)=54
54 % 10 = 4
So 202000-98-4 is a valid CAS Registry Number.
202000-98-4Relevant academic research and scientific papers
Kowalczyk, Bruce A.
, p. 1411 - 1414 (1997)
A simple synthetic strategy to dihalophenylacetic acids and specifically 3,5-difluorophenylacetic acid an important pharmaceutical intermediate was developed. The aromatic nucleophilic substitution of dihalofluorobenzenes using the anion of ethyl cyanoacetate yielded ethyl dihalophenylcyanoacetates. The basic decarboxylation of the ethyl dihalophenylcyanoacetates produced targeted dihalophenylacetic acids.
